Effects of oligodeoxynucleotides on the physicochemical characteristics and cellular uptake of liposomes

被引:19
作者
Arima, H [1 ]
Aramaki, Y [1 ]
Tsuchiya, S [1 ]
机构
[1] TOKYO UNIV PHARM & LIFE SCI, SCH PHARM, HACHIOJI, TOKYO 19203, JAPAN
关键词
D O I
10.1021/js9603865
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We studied the effects of a phosphodiester oligodeoxynucleotide (ODN), which is antisense to the site in the neighborhood of the AUG initiation codon of the mouse tumor necrosis factor alpha gene (TNF-alpha), on the physicochemical characteristics and the cellular association of three types of liposomes with different surface charges. The physicochemical characteristics of the liposomes changed after adding ODN. When the ODN/lipid molar ratio was similar to 0.15 in cationic (TMAG) liposomes [consisting of N-(alpha-trimethylammonioacetyl)didodecyl-D-glutamate chloride (TMAG), dilauroylphosphatidylcholine (DLPC), and dioleolylphosphatidylethanolamine (DOPE) in a 1:2:2 ratio], but not in neutral and negatively charged liposomes, then the liposomes aggregated and fused. At higher molar ratios, these changes in TMAG liposomes were not evident. In addition, ODN inverted the zeta-potential of TMAG liposomes from positive to negative at an ODN/lipid molar ratio of similar to 0.15. Therefore, the aggregation and fusion induced by ODN could be explained by a lower surface charge repulsion between TMAG liposomes. On the other hand, the association of ODN with RAW264.7 cells, a mouse macrophage-like cell line, was very slight. The cellular association of ODN was significantly enhanced compared with neutral and negatively charged liposomes by encapsulation in TMAG liposomes. The ODN added to liposome suspensions did not affect the rate and extent of TMAG liposome cellular association, even at an ODN/lipid molar ratio of similar to 0.15. These results indicate that the lipid composition and ODN/lipid molar ratio are critical for the physicochemical characteristics of cationic liposomes. However, the changes had less influence on the cellular uptake properties of cationic liposomes.
引用
收藏
页码:438 / 442
页数:5
相关论文
共 50 条
  • [1] STABILITY OF ANTISENSE DNA OLIGODEOXYNUCLEOTIDE ANALOGS IN CELLULAR-EXTRACTS AND SERA
    AKHTAR, S
    KOLE, R
    JULIANO, RL
    [J]. LIFE SCIENCES, 1991, 49 (24) : 1793 - 1801
  • [2] INTERACTIONS OF ANTISENSE DNA OLIGONUCLEOTIDE ANALOGS WITH PHOSPHOLIPID-MEMBRANES (LIPOSOMES)
    AKHTAR, S
    BASU, S
    WICKSTROM, E
    JULIANO, RL
    [J]. NUCLEIC ACIDS RESEARCH, 1991, 19 (20) : 5551 - 5559
  • [3] UPTAKE OF LIPOSOMES BY CULTURED MOUSE BONE-MARROW MACROPHAGES - INFLUENCE OF LIPOSOME COMPOSITION AND SIZE
    ALLEN, TM
    AUSTIN, GA
    CHONN, A
    LIN, L
    LEE, KC
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1061 (01) : 56 - 64
  • [4] ANTIVIRAL ACTIVITY IN L1210 CELLS OF LIPOSOME-ENCAPSULATED (2'-5')OLIGO(ADENYLATE) ANALOGS
    BAYARD, B
    LESERMAN, LD
    BISBAL, C
    LEBLEU, B
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1985, 151 (02): : 319 - 325
  • [5] BENNETT CF, 1992, MOL PHARMACOL, V41, P1023
  • [6] HYBRIDIZATION ARREST OF GLOBIN-SYNTHESIS IN RABBIT RETICULOCYTE LYSATES AND CELLS BY OLIGODEOXYRIBONUCLEOSIDE METHYLPHOSPHONATES
    BLAKE, KR
    MURAKAMI, A
    SPITZ, SA
    GLAVE, SA
    REDDY, MP
    TSO, POP
    MILLER, PS
    [J]. BIOCHEMISTRY, 1985, 24 (22) : 6139 - 6145
  • [7] CATIONIC LIPIDS IMPROVE ANTISENSE OLIGONUCLEOTIDE UPTAKE AND PREVENT DEGRADATION IN CULTURED-CELLS AND IN HUMAN SERUM
    CAPACCIOLI, S
    DIPASQUALE, G
    MINI, E
    MAZZEI, T
    QUATTRONE, A
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (02) : 818 - 825
  • [8] ADSORPTION OF OLIGONUCLEOTIDES ONTO POLYISOHEXYLCYANOACRYLATE NANOPARTICLES PROTECTS THEM AGAINST NUCLEASES AND INCREASES THEIR CELLULAR UPTAKE
    CHAVANY, C
    SAISONBEHMOARAS, T
    LEDOAN, T
    PUISIEUX, F
    COUVREUR, P
    HELENE, C
    [J]. PHARMACEUTICAL RESEARCH, 1994, 11 (09) : 1370 - 1378
  • [9] MICRODETERMINATION OF PHOSPHORUS
    CHEN, PS
    TORIBARA, TY
    WARNER, H
    [J]. ANALYTICAL CHEMISTRY, 1956, 28 (11) : 1756 - 1758
  • [10] CLARENC JP, 1993, ANTI-CANCER DRUG DES, V8, P81